Lumeris
PrivateLast Round
Growth Equity
Apr 22, 2024
Est. Valuation
$1B
Total Funding Raised
$523.31M
Company Overview
Lumeris is a healthcare technology company that provides a value-based care managed services platform and AI-powered solutions to health systems, payers, and physician groups.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, InsurTech, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumeris Comparables
Compare Lumeris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aledade | 84% | |
| Privia Health Group Inc | 81% | |
| Arcadia | 79% |
Lumeris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Apr 22, 2024 | ||||
| Strategic | Jul 9, 2018 | ||||
| Debt | Apr 22, 2016 | ||||
| VC Round | Jul 24, 2014 | ||||
| Private Equity | Oct 25, 2011 | ||||
Private Equity | Jul 19, 2011 |
Lumeris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Growth Equity |
| NimbleVentures | Growth Equity |
| Blue Cross Blue Shield Association | Growth Equity |
| Kleiner Perkins | Growth Equity, Private Equity, VC Round |
| Camden Partners | Private Equity, VC Round |
| Blue Venture Fund | Growth Equity, Private Equity |
| Sandbox Industries | Growth Equity, VC Round, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Deep collaboration with Essence Healthcare on quality and Medicare Stars strategy.
- Apr 24, 2026
AI platform 'Tom' launched with over 100 EHR integrations.
Recent news
Latest coverage and updates
- hiresOct 20, 2026
On Oct 20th '26 in Massachusetts, Lumeris announces that Charles "Chuck" Saunders, M.D., joins as chief clinical transformation officer and president of Value-Based Care Enablement, where he leads the business and provides clinical oversight for the Tom platform.
- recognized_asSep 24, 2026
Lumeris is named to TIME and Statista’s World’s Top HealthTech Companies list for 2026 and earns an “Outstanding” rating in AI & Data Analytics.
Lumeris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lumeris's valuation, stock price, and market status.
Is Lumeris a public or private company?
Lumeris is a private company.
What is the current stock price of Lumeris?
Lumeris is a private company, so its shares have no public market price. Caplight tracks Lumeris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumeris worth (valuation)?
Lumeris's valuation is estimated at $1.0B based on funding round data.
Can I buy Lumeris stock?
Lumeris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumeris's last funding round?
Lumeris's most recent funding round was Growth Equity on April 22, 2024.
Who are the main investors in Lumeris?
Key investors in Lumeris include Deerfield Management, Kleiner Perkins, Blue Venture Fund.
Will Lumeris IPO soon?
No public IPO plans have been announced for Lumeris.
How can I track Lumeris secondary market activity?
Caplight tracks bids, offers, and trades in Lumeris's shares on secondary markets.